Daily FNArena News

An expected two-month payback from the Cadlao project in the Philippines is enough for DJ Carmichael to initiate coverage on junior oil play Raisama with a Spec Buy rating.

Aussie biotech junior Bionomics has received positive results from early trials of an anti-anxiety compound and Bell Potter sees enough potential upside to rate the stock a Speculative Buy.

This week’s Tweets by Your Editor on Twitter.

Investment experts and technical chartists are being forced to re-write scenarios as equities continue selling-off.

CLSA has initiated coverage of the Australian retail sector, pitching earnings forecasts 20-30% below consensus for the next two years.

Norfolk’s AGM commentary included a reiteration of earnings guidance for FY12 which underscores a Buy rating from Moelis.

Daily update on share prices and consensus price targets.

A glance through the latest expert views and predictions about commodities with positives identified for precious metals, iron ore and aluminium, disappointments for copper supply and potential energy sector catalysts.

Well-defined share price ranges offer opportunities for traders, reports the TechWizard.

The Chartist reports Chinese equities need to push higher, before a bullish pattern can emerge.